Company intelligence / Profile preview

Cookuk

West Lafayette, Indiana, United Statescookuk.co.uk ↗

Ownership: Private
Development stage: Commercial

Overview

Cook Biotech has developed and commercialized advanced tissue-repair products based on proprietary extracellular matrix technologies. Over 17 million implants have been distributed globally for a variety of clinical applications including wound healing, soft tissue repair, nerve regeneration, and cardiovascular procedures. The company’s SIS-based products support site-specific tissue remodeling with proven clinical outcomes.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Extracellular matrix biomaterialsXenograft biomaterialsAllograft biomaterials
Industry: Implantable Medical Devices

Partnerships

Smith & NephewAcuityBioAxoGenCorza OphthalmologyElutiaKeystone Dental GroupSanara MedTechTorigen PharmaceuticalsVetrix

Beyond the preview

Go deeper on Cookuk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cookuk.

Explore the full profile